Regulation of T cell development and maturation by NKAP
Regulation of T cell development and maturation by NKAP
批准号:
8415926
负责人:
Virginia Smith Shapiro
金额:
$35.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-01-15 至 2014-12-31
关键词:
AllelesAntigensApoptosisCD28 geneCell Cycle ProgressionCell LineCell MaturationCellsChemosensitizationComplementComplexDefectDeltex Homolog 1DevelopmentEmigrantEpigenetic ProcessFailureGene ExpressionGene Expression RegulationGene TargetingGenerationsGeneric DrugsGeneticIL2RA geneImmuneImmune responseKnockout MiceLeukocytesLibrariesMusPlayProteinsRegulationRepressionRoleSignal TransductionStagingT-Cell ActivationT-Cell DevelopmentT-Cell ReceptorT-LymphocyteThymocyte DevelopmentTranscription Repressor/CorepressorUp-Regulationin vivomutantnotch proteinnovelpublic health relevancethymocyte
中文摘要
说明书(申请人提供):T细胞激活涉及几个信号的整合。除了通过T细胞受体(TCR)的抗原特异性信号和通过CD28等分子的共刺激信号外,通过包括跨膜受体Notch在内的其他分子的信号在T细胞激活和发育的许多阶段都是至关重要的。为了确定调节T细胞激活的新分子,我们使用了一种遗传方法,通过逆转录病毒表达白细胞库来挽救Jurkat突变细胞系中的T细胞激活缺陷。在我们的初步筛选中,我们发现逆转录病毒表达的NKAP弥补了一个Jurkat突变细胞系的缺陷,并恢复了T细胞的激活。我们已经证明,NKAP是一种新的Notch信号负调控因子,与CIR有关,CIR是Notch共抑制物复合体的一部分。为了确定NKAP在体内的功能,我们产生了一个NKAP等位基因。在DN3/2选择检查点,LCK-cre NKAP条件性基因敲除小鼠的T细胞发育严重受阻,尽管T细胞发育正常。有趣的是,缺乏NCoR或mSin3a的小鼠在T细胞发育过程中也会出现DN3阻断,这表明当细胞通过选择检查点成为DP T细胞时,表观遗传学变化是必要的。不出所料,QPCR检测了三个Notch靶基因CD25、Deltex 1和Hes1,发现NKAP lck-cre CKO DP T细胞的基因表达增加了8~20倍,证明NKAP在体内是Notch信号的负调控因子,是T细胞发育所必需的。对CD4cre NKAP CKO小鼠T细胞发育的分析表明,在SP胸腺细胞从半成熟到成熟的过程中,它们被阻断了。此外,CD4cre NKAP CKO小鼠外周血中T细胞数量减少,这些幼稚的T细胞表达的标志与胸腺新近迁出的T细胞一致,表明NKAP在T细胞成熟过程中也起着关键作用。这项建议将侧重于了解NKAP在T细胞发育和成熟过程中的功能,揭示在缺乏NKAP的情况下基因调控改变如何改变T细胞发育,并确定NKAP丢失导致Notch靶基因上调的机制。特异性目标1:NKAP对T细胞发育和成熟的调节
英文摘要
DESCRIPTION (provided by applicant): T cell activation involves the integration of several signals. In addition to antigen specific signaling through the T cell receptor (TCR) and costimulatory signaling through molecules such as CD28, signaling through additional molecules including the transmembrane receptor Notch are critical at many stages of T cell activation and development. To identify novel molecules that regulate T cell activation, we used a genetic approach to rescue the T cell activation defect in a Jurkat mutant cell line by retroviral expression of a leukocyte library. In our initial screen, we found that retroviral expression of NKAP complemented the defect in one Jurkat mutant cell line and restored T cell activation. We have demonstrated that NKAP is a novel negative regulator of Notch signaling that associates with CIR, which is part of the Notch co-repressor complex. To determine the function of NKAP in vivo, we generated mice with a floxed NKAP allele. Lck-cre NKAP conditional knockout mice have a severe block in ??T cell development at the DN3/2-selection checkpoint, although ??T cell development proceeds normally. Interestingly, mice deficient in either NcoR or mSin3a, two generic components of transcriptional corepressor complexes, also have a DN3 block during T cell development, indicating that epigenetic changes are required as cells pass the ?-selection checkpoint to become DP T cells. As predicted, examination of three Notch target genes, CD25, Deltex1 and Hes1 by QPCR demonstrated that NKAP lck-cre cKO DP T cells had increases in gene expression by 8- to 20-fold, proving that the NKAP functions as a negative regulator of Notch signaling in vivo, and is required for T cell development. Analysis of T cell development in CD4-cre NKAP cKO mice demonstrates a block within SP thymocytes as they progress from semimature to mature. In addition, there are decreased numbers of T cells in the periphery in CD4-cre NKAP cKO mice, and these naive T cells express markers consistent with being recent thymic emigrants, indicating that NKAP also plays a critical role in T cell maturation. This proposal will focus on understanding the function of NKAP during T cell development and maturation, to uncover how altered gene regulation in the absence of NKAP alters T cell development and to define the mechanism whereby loss of NKAP leads to upregulation of Notch target genes. Specific Aim #1: Regulation of T cell development and maturation by NKAP Specific Aim #2: Mechanism of altered gene expression in the absence of NKAP
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Altered TCR signaling in anergy
-
批准号:10750486
-
项目类别:
-
资助金额:$24.21万
-
财政年份:2023
-
负责人:Virginia Smith Shapiro
-
依托单位:
Training Program in Immunology
-
批准号:10493678
-
项目类别:
-
资助金额:$15.84万
-
财政年份:2022
-
负责人:Virginia Smith Shapiro
-
依托单位:
Training Program in Immunology
-
批准号:10650170
-
项目类别:
-
资助金额:$32.29万
-
财政年份:2022
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of B cell development by ABCB7
-
批准号:10374116
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2021
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of gene expression by HDAC3
-
批准号:10455700
-
项目类别:
-
资助金额:$50.57万
-
财政年份:2020
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of gene expression by HDAC3
-
批准号:10667604
-
项目类别:
-
资助金额:$50.57万
-
财政年份:2020
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of gene expression by HDAC3
-
批准号:10225415
-
项目类别:
-
资助金额:$50.57万
-
财政年份:2020
-
负责人:Virginia Smith Shapiro
-
依托单位:
ST8Sia6 expression on tumors inhibits the immune response
-
批准号:10308083
-
项目类别:
-
资助金额:$39.14万
-
财政年份:2019
-
负责人:Virginia Smith Shapiro
-
依托单位:
ST8Sia6 expression on tumors inhibits the immune response
-
批准号:10529298
-
项目类别:
-
资助金额:$39.14万
-
财政年份:2019
-
负责人:Virginia Smith Shapiro
-
依托单位:
ST8Sia6 expression on tumors inhibits the immune response
-
批准号:9913027
-
项目类别:
-
资助金额:$40.6万
-
财政年份:2019
-
负责人:Virginia Smith Shapiro
-
依托单位:
ST8Sia6 expression on tumors inhibits the immune response
-
批准号:10054986
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2019
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of T cell development by HDAC3
-
批准号:9543129
-
项目类别:
-
资助金额:$60.29万
-
财政年份:2017
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of hematopoietic stem cell maintenance and survival by NKAP
-
批准号:8823656
-
项目类别:
-
资助金额:$39.15万
-
财政年份:2013
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of hematopoietic stem cell maintenance and survival by NKAP
-
批准号:8531478
-
项目类别:
-
资助金额:$37.84万
-
财政年份:2013
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of hematopoietic stem cell maintenance and survival by NKAP
-
批准号:8666663
-
项目类别:
-
资助金额:$38.96万
-
财政年份:2013
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of hematopoietic stem cell maintenance and survival by NKAP
-
批准号:9040250
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2013
-
负责人:Virginia Smith Shapiro
-
依托单位:
The Role for NKAP in iNKT cell development
-
批准号:8316095
-
项目类别:
-
资助金额:$19.71万
-
财政年份:2011
-
负责人:Virginia Smith Shapiro
-
依托单位:
The Role for NKAP in iNKT cell development
-
批准号:8087797
-
项目类别:
-
资助金额:$23.66万
-
财政年份:2011
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of T cell development and maturation by NKAP
-
批准号:8011439
-
项目类别:
-
资助金额:$37.4万
-
财政年份:2010
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of T cell maturation
-
批准号:9190269
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2010
-
负责人:Virginia Smith Shapiro
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: